ITeos Therapeutics Newsroom

Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $19

Moomoo NewsDec 20 13:44 ET

Wells Fargo Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $19

BenzingaDec 19 09:59 ET

ITeos Therapeutics Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow JonesDec 13 06:37 ET

H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $21

Moomoo NewsDec 13 06:31 ET

ITeos Therapeutics Analyst Ratings

BenzingaDec 13 06:28 ET

Strategic Focus on Belrestotug Drives Buy Rating for ITeos Therapeutics With Adjusted Price Target of $21

TipRanksDec 13 06:18 ET

ITeos Therapeutics Analyst Ratings

BenzingaNov 15 07:36 ET

H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $46

Moomoo NewsNov 15 06:31 ET

Leerink Partners Maintains ITeos Therapeutics(ITOS.US) With Buy Rating

Moomoo NewsNov 14 03:33 ET

Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsNov 13 06:36 ET

Strategic Catalysts and Financial Stability Underpin Buy Rating for ITeos Therapeutics

TipRanksNov 13 05:50 ET

Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsSep 17 05:32 ET

ITeos Therapeutics Analyst Ratings

BenzingaSep 16 07:42 ET

Piper Sandler Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsSep 16 07:31 ET

ITeos Therapeutics (ITOS) Receives a Buy From Piper Sandler

TipRanksSep 16 06:59 ET

H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $46

Moomoo NewsSep 16 06:31 ET

Wedbush Raises Price Target on ITeos Therapeutics to $25 From $21, Keeps Outperform Rating

MT NewswiresSep 16 06:27 ET

Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsSep 14 09:32 ET

Buy Rating Affirmed for ITeos Therapeutics Amid Promising Lung-201 Study Outcomes

TipRanksSep 14 08:58 ET

J.P. Morgan Sticks to Its Buy Rating for ITeos Therapeutics (ITOS)

TipRanksAug 13 08:34 ET